OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
In brief
- What: OpenAI acquires Orchestra Bio
- When: October 20, 2026 at 03:00
- Source: OpenAI (primary source)
- Also reported by: TechCrunch AI, SiliconANGLE AI
- Topic: Business
Prepared by Ilya Tarasov’s Tarasov Code newsroom based on a report by OpenAI.
